U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07940647) titled 'A Safety and Tolerability Study of HJB647 in Adult Participants With Uncontrolled Hypertension' on Nov. 11.

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of HJB647 at different doses in participants with uncontrolled hypertension (uHTN)

Study Start Date: Nov. 23

Study Type: INTERVENTIONAL

Condition: Uncontrolled Hypertension

Intervention: DRUG: HJB647

HJB647 oral capsules administered in adult participants with uncontrolled hypertension

DRUG: Placebo

Matching placebo capsules administered orally

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Novartis Pharmaceutical...